Table: Daito - 9-MTH group results

Daito Pharmaceutical

14/04/2022 07:00

Apr 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2022        Feb 28, 2021     May 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             33.58               37.84            42.50    
                                     (+10.1 pct)      (+6.2 pct)  
  Operating          5.65                5.34             5.90    
                 (+5.8 pct)          (+16.4 pct)      (-0.1 pct)  
  Recurring          5.79                5.42             6.00    
                 (+6.9 pct)          (+16.8 pct)      (-1.1 pct)  
  Net                3.98                3.70             4.25    
                 (+7.5 pct)          (+14.2 pct)      (+0.1 pct)  
  EPS            287.81 yen          271.39 yen       309.91 yen  
  Ann Div                             46.00 yen        60.00 yen  
  -Q2 div         25.00 yen           23.00 yen                   
  -Q4 div                             23.00 yen        35.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T